investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Enhancing Chemo-Response in Triple-Negative Breast Cancer by Activiating T-Cell Response
Dihua Yu
2 Collaborator(s)
Funding source
University of Texas MD Anderson Cancer Center
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Ana Soto
Mechanism of developmental toxicity of Bisphenol-A
Breast
Pathology
Christopher H Contag
Dynamic Imaging of EMT in the Breast Cancer Microenvironment
Breast
Gregg B Fields
Mechanism and Inhibition of Collagenolytic Activity
Breast
Charlotte Kuperwasser
Analysis of the cellular and molecular determinants of the human breast hierarchy
Breast
Pathology
Roger W Howell
Radiation induced bystander effects in radium-223 therapy
Breast
Radiation Oncology
Thomas Spies
Stimulation of Tumorigenesis by NKG2D
Breast
Pathology
Esta Sterneck
Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells
Breast
Valen Earl Johnson
Consistent Model Selection in the p>>n Setting
Breast
William J Murphy
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
Breast